Carmat is focused on the research and development of an innovative product in the medical sector, developing an orthotopic and biocompatible artificial heart which is completely implantable, as well as its electrical power supply system and remote diagnosis system. Co. is developing a long-term therapeutic solution for patients who suffer from advanced bi-ventricular heart failure and who are not eligible for cardiac transplantation and who have exhausted all drug possibilties. Co. is still in the phase of research and development and thus do not generate any revenues.

Dont Nod Entertainment SA. Dont Nod Entertainment SARL is a France-based video game developer. The Company develops video games for consoles and personal computers (PC) based on original concepts and technologies. The Company specializes in narrative games in a number of genres, including adventure, action and role play. Its games are natively multi-screens (consoles, PCs, Smartphone, tablets, Mac and TV). Its game portfolio includes Remember me, which includes digitized personal and intimate memories; Life is Strange, which narrates the story of Max, a photography student who suddenly discovers an internal power to go back in time, and Vampyr, which depicts London in the early 20th century after it has been ravaged by the Spanish Flu.

Nanobiotix SA is a France-based oncology focused nanomedicine company. It is engaged in developing nanoparticle technology. It develops new tools for cancer which utilize a physical mode of action at the cellular level of the cancer cell. This disruptive approach may reshape future treatment opportunities. The Company's NanoXray technology comprises three products having the potential to cause a paradigm shift in cancer therapy. Specifically, NanoXray products may overcome the current limitations of standard of care in local therapy. Local treatment (surgery and radiotherapy) plays a seminal role in the potential cure and gives systemic treatment a better chance to increase life expectancy. NanoXray products are developed to selectively increase the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.